LYMPHOMA, MANTLE CELL

Clinical trials for LYMPHOMA, MANTLE CELL explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA, MANTLE CELL trials appear

Sign up with your email to follow new studies for LYMPHOMA, MANTLE CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 5 Completed 3

Promising drug cocktail takes on tough lymphoma

Disease control Recruiting now

This phase 2 trial is testing a combination of three drugs—glofitamab, venetoclax, and zanubrutinib—in people with high-risk mantle cell lymphoma, either newly diagnosed or after relapse. The study will enroll 100 participants across three groups based on their treatment history.…

Matched conditions: LYMPHOMA, MANTLE CELL

Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control

Last updated Jun 27, 2026 09:05 UTC

LYMPHOMA, MANTLE CELL

Get alerted when new LYMPHOMA, MANTLE CELL trials appear

Promising drug cocktail takes on tough lymphoma